It is studied in adults with overweight or obesity (BMI 27 or higher in REDEFINE 1) and in adults with type 2 diabetes (REDEFINE 2 and REIMAGINE 2)
Safe Titration and Monitoring: Both medications require a gradual increase in dosage (titration) over several weeks or months to minimize common, temporary side effects like nausea, vomiting, and digestive issues
Ready to learn more about Olympias physician-guided injection therapies
The only solution that covers the 3 key elements to help you lose up to 20% total body weight and keep it off
May 25, 2026$200/mo July 6, 2026$200/mo July 13, 2026$200/mo July 20, 2026$200/mo July 27, 2026$200/mo We check Ivim Healths published pricing every Monday
Grand View Research forecasts the GLP-1 drug market to grow by a CAGR of nearly 19% through 2030